42OA phase 1 study of CPI-1205, a small molecule inhibitor of EZH2, preliminary safety in patients with B-cell lymphomas. (5th March 2018)

Record Type:: Journal Article
Title:: 42OA phase 1 study of CPI-1205, a small molecule inhibitor of EZH2, preliminary safety in patients with B-cell lymphomas. (5th March 2018)
Main Title:: 42OA phase 1 study of CPI-1205, a small molecule inhibitor of EZH2, preliminary safety in patients with B-cell lymphomas
Authors:: Harb, W
Abramson, J
Lunning, M
Goy, A
Maddocks, K
Lebedinsky, C
Senderowicz, A
Trojer, P
Bradley, W D
Flinn, I
Abstract:
Is Part Of:: Annals of oncology. Volume 29(2018)Supplement 3
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 3
Issue Display:: Volume 29, Issue 3 (2018)
Year:: 2018
Volume:: 29
Issue:: 3
Issue Sort Value:: 2018-0029-0003-0000
Page Start:
Page End:
Publication Date:: 2018-03-05
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy048.001 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12259.xml